In contrast, bone morphogenetic protein-7 (BMP-7) strongly antagonizes fibrogenic actions of TGF-beta2 on human trabecular meshwork cells, indicating that a pharmacological modulation of BMP-7 signaling might be a promising strategy to treat primary open-angle glaucoma [21]. The gene discussed is BMP7; the disease is open-angle glaucoma.